Axa S.A. Sells 27,490 Shares of Envista Holdings Co. (NYSE:NVST)

AXA S.A. lessened its holdings in Envista Holdings Co. (NYSE:NVST - Free Report) by 21.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 98,441 shares of the company's stock after selling 27,490 shares during the period. AXA S.A. owned 0.06% of Envista worth $1,899,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of NVST. Treasurer of the State of North Carolina raised its position in shares of Envista by 0.6% during the 4th quarter. Treasurer of the State of North Carolina now owns 75,560 shares of the company's stock worth $1,458,000 after purchasing an additional 480 shares during the last quarter. Amalgamated Bank raised its holdings in shares of Envista by 0.7% in the fourth quarter. Amalgamated Bank now owns 80,380 shares of the company's stock worth $1,551,000 after acquiring an additional 523 shares during the last quarter. GAMMA Investing LLC boosted its stake in shares of Envista by 30.5% during the fourth quarter. GAMMA Investing LLC now owns 2,304 shares of the company's stock valued at $44,000 after acquiring an additional 538 shares during the last quarter. M&T Bank Corp boosted its stake in shares of Envista by 4.2% during the fourth quarter. M&T Bank Corp now owns 16,621 shares of the company's stock valued at $320,000 after acquiring an additional 676 shares during the last quarter. Finally, Assetmark Inc. increased its position in Envista by 2.5% during the 4th quarter. Assetmark Inc. now owns 39,624 shares of the company's stock worth $764,000 after purchasing an additional 983 shares in the last quarter.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on NVST shares. Wells Fargo & Company set a $19.00 target price on shares of Envista in a research report on Saturday, March 8th. Piper Sandler decreased their price objective on Envista from $18.00 to $17.00 and set a "neutral" rating on the stock in a report on Wednesday, April 30th. UBS Group dropped their target price on Envista from $21.00 to $18.00 and set a "neutral" rating for the company in a research note on Monday, May 5th. Morgan Stanley set a $16.00 price target on Envista in a research note on Tuesday, April 15th. Finally, New Street Research set a $19.00 price objective on shares of Envista in a research note on Thursday, March 6th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $20.08.

Envista Stock Performance

NYSE:NVST traded down $0.53 during midday trading on Wednesday, reaching $18.08. The stock had a trading volume of 439,183 shares, compared to its average volume of 2,517,316. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.04 and a quick ratio of 1.76. The firm's fifty day simple moving average is $16.50 and its 200-day simple moving average is $18.99. The stock has a market capitalization of $3.06 billion, a P/E ratio of -2.79, a PEG ratio of 1.27 and a beta of 0.97. Envista Holdings Co. has a 1-year low of $14.22 and a 1-year high of $23.00.

Envista (NYSE:NVST - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The company reported $0.24 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.20 by $0.04. The business had revenue of $616.90 million for the quarter, compared to analysts' expectations of $608.17 million. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. Envista's quarterly revenue was down 1.1% on a year-over-year basis. During the same period in the previous year, the business posted $0.26 earnings per share. On average, equities research analysts forecast that Envista Holdings Co. will post 1 EPS for the current fiscal year.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.